循環器ジャーナル70巻1号

2022年01月発行

特集 心筋症診療のフロントライン—概念から最新の治療まで Ⅱ章　心筋症の病因—何が解って，何が解っていないか

心筋症の病因としての遺伝子変異

著者： 野村征太郎¹

所属機関： ¹東京大学医学部附属病院循環器内科

ページ範囲：P.13 - P.16

Point
・心筋症は遺伝子変異で発症する．
・遺伝子変異のタイプによって心筋症の病態が異なる．
・分子機序を標的とした治療法も開発されている．
・遺伝子変異に他のレイヤーを紐づけて，層別化や治療法開発がさらに進む．

参考文献

1）Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al : A molecular basis for familial hypertrophic cardiomyopathy : a beta cardiac myosin heavy chain gene missense mutation. Cell 62 : 999-1006, 1990

2）Olson TM, Michels VV, Thibodeau SN, et al : Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280 : 750-752, 1998

3）McNally EM, Mestroni L : Dilated Cardiomyopathy Genetic Determinants and Mechanisms. Circ Res 121 : 731-748, 2017

4）Tadros R, Francis C, Xu X, et al : Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect. Nat Genet 53 : 128-134, 2021 doi : 10.1038/s41588-020-00762-2. Epub 2021 Jan 25. PMID : 33495596.

5）Harper AR, Goel A, Grace C, et al : Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat Genet 53 : 135-142, 2021 doi : 10.1038/s41588-020-00764-0. Epub 2021 Jan 25. PMID : 33495597.

6）Herman DS, Lam L, Taylor MR, et al : Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366 : 619-628, 2012

7）Ware JS, Amor-Salamanca A, Tayal U, et al : Genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol 71 : 2293-2302, 2018

8）Ware JS, Li J, Mazaika E, et al : Shared genetic predisposition in peripartum and dilated cardiomyopathies. N Engl J Med 374 : 233-241, 2016

9）Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, et al : Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy. Circulation 140 : 31-41, 2019

10）Povysil G, Chazara O, Carss KJ, et al : Assessing the Role of Rare Genetic Variation in Patients With Heart Failure. JAMA Cardiol 6 : 379-386, 2021 doi : 10.1001/jamacardio.2020.6500. PMID : 33326012 ; PMCID : PMC7745141.

11）Mazzarotto F, Olivotto I, Boschi B, et al : Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy : Toward a New Era in Clinical Testing? J Am Heart Assoc 9 : e015473, 2020 doi : 10.1161/JAHA.119.015473. Epub 2020 Apr 18. PMID : 32306808 ; PMCID : PMC7428545.

12）Miron A, Lafreniere-Roula M, Steve Fan CP, et al : A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy. Circulation 142 : 217-229, 2020 doi : 10.1161/CIRCULATIONAHA.120.047235. Epub 2020 May 18. PMID : 32418493 ; PMCID : PMC7365676.

13）Marstrand P, Han L, Day SM, et al ; SHaRe Investigators : Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction : Insights From the SHaRe Registry. Circulation 141 : 1371-1383, 2020 doi : 10.1161/CIRCULATIONAHA.119.044366. Epub 2020 Mar 31. PMID : 32228044 ; PMCID : PMC7182243.

14）Lorenzini M, Norrish G, Field E, et al : Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers. J Am Coll Cardiol 76 : 550-559, 2020 doi : 10.1016/j.jacc.2020.06.011. PMID : 32731933 ; PMCID : PMC7397507.

15）Hoss S, Habib M, Silver J, et al : Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics : Yield and Clinical Significance. Circ Genom Precis Med 13 : e002748, 2020 doi : 10.1161/CIRCGEN.119.002748. Epub 2020 Mar 9. PMID : 32150461.

16）Tobita T, Nomura S, Fujita T, et al : Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep 8 : 1998, 2018 doi : 10.1038/s41598-018-20114-9. PMID : 29386531 ; PMCID : PMC5792481.

17）Hasselberg NE, Haland TF, Saberniak J, et al : Lamin A/C cardiomyopathy : young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J 39 : 853-860, 2018 doi : 10.1093/eurheartj/ehx596. PMID : 29095976 ; PMCID : PMC5939624.

18）日本循環器学会，日本心不全学会，日本心臓病学会，他：日本循環器学会/日本心不全学会合同ガイドライン　心筋症診療ガイドライン（2018年改訂版）．2019年3月29日発行，2021年6月22日更新

19）Smith ED, Lakdawala NK, Papoutsidakis N, et al : Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 141 : 1872-1884, 2020 doi : 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6. PMID : 32372669 ; PMCID : PMC7286080.

20）Toepfer CN, Wakimoto H, Garfinkel AC, et al : Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin. Sci Transl Med 11 : eaat1199, 2019

21）Green EM, Wakimoto H, Anderson RL, et al : A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351 : 617-621, 2016

22）Olivotto I, Oreziak A, Barriales-Villa R, et al ; EXPLORER-HCM study investigators : Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy（EXPLORER-HCM） : a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 396 : 759-769, 2020

23）Teerlink JR, Diaz R, Felker GM, et al ; GALACTIC-HF Investigators : Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. N Engl J Med 384 : 105-116, 2021

24）Sinagra G, Elliott PM, Merlo M : Dilated cardiomyopathy : so many cardiomyopathies! Eur Heart J 41 : 3784-3786, 2020 doi : 10.1093/eurheartj/ehz908. PMID : 31872205.

25）Rajewsky N, Almouzni G, Gorski SA, et al ; LifeTime Community Working Groups : LifeTime and improving European healthcare through cell-based interceptive medicine. Nature 587 : 377-386, 2020 doi : 10.1038/s41586-020-2715-9. Epub 2020 Sep 7. Erratum in : Nature. 2021 Apr ; 592（7852） : E8. PMID : 32894860 ; PMCID : PMC7656507.

26）Nomura S, Satoh M, Fujita T, et al : Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure. Nat Commun 9 : 4435, 2018 doi : 10.1038/s41467-018-06639-7. PMID : 30375404 ; PMCID : PMC6207673.

27）Ko T, Fujita K, Nomura S, et al : Quantification of DNA Damage in Heart Tissue as a Novel Prediction Tool for Therapeutic Prognosis of Patients With Dilated Cardiomyopathy. JACC Basic Transl Sci 4 : 670-680, 2019 doi : 10.1016/j.jacbts.2019.05.010. PMID : 31709317 ; PMCID : PMC6834953.

28）Yamaguchi T, Sumida TS, Nomura S, et al : Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure. Nat Commun 11 : 4364, 2020 doi : 10.1038/s41467-020-18128-x. PMID : 32868781 ; PMCID : PMC7459304.

29）Verdonschot JAJ, Merlo M, Dominguez F, et al : Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences. Eur Heart J 42 : 162-174, 2021 doi : 10.1093/eurheartj/ehaa841. PMID : 33156912 ; PMCID : PMC7813623.

30）Scala F, Kobak D, Bernabucci M, et al : Phenotypic variation of transcriptomic cell types in mouse motor cortex. Nature 598 : 144-150, 2021 doi : 10.1038/s41586-020-2907-3. Epub 2020 Nov 12. PMID : 33184512 ; PMCID : PMC8113357.

31）Wang Z, Grange M, Wagner T, et al : The molecular basis for sarcomere organization in vertebrate skeletal muscle. Cell 184 : 2135-2150. e13, 2021 doi : 10.1016/j.cell.2021.02.047. Epub 2021 Mar 24. PMID : 33765442 ; PMCID : PMC8054911.

32）Gillmore JD, Gane E, Taubel J, et al : CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. N Engl J Med 385 : 493-502, 2021 doi : 10.1056/NEJMoa2107454. Epub 2021 Jun 26. PMID : 34215024.